Brain tissue segmentation in multi-modal magnetic resonance (MR) images is significant for the clinical diagnosis of brain diseases. Due to blurred boundaries, low contrast, and intricate anatomical relationships between brain tissue regions, automatic brain tissue segmentation without prior knowledge is still challenging. This paper presents a novel 3D fully convolutional network (FCN) for brain tissue segmentation, called APRNet. In this network, we first propose a 3D anisotropic pyramidal convolutional reversible residual sequence (3DAPC-RRS) module to integrate the intra-slice information with the inter-slice information without significant memory consumption; secondly, we design a multi-modal cross-dimension attention (MCDA) module to automatically capture the effective information in each dimension of multi-modal images; then, we apply 3DAPC-RRS modules and MCDA modules to a 3D FCN with multiple encoded streams and one decoded stream for constituting the overall architecture of APRNet. We evaluated APRNet on two benchmark challenges, namely MRBrainS13 and iSeg-2017. The experimental results show that APRNet yields state-of-the-art segmentation results on both benchmark challenge datasets and achieves the best segmentation performance on the cerebrospinal fluid region. Compared with other methods, our proposed approach exploits the complementary information of different modalities to segment brain tissue regions in both adult and infant MR images, and it achieves the average Dice coefficient of 87.22% and 93.03% on the MRBrainS13 and iSeg-2017 testing data, respectively. The proposed method is beneficial for quantitative brain analysis in the clinical study, and our code is made publicly available.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1109/JBHI.2021.3093932 | DOI Listing |
J Neuroinflammation
January 2025
Department of Molecular and Integrative Physiology, University of Michigan Medical School, Ann Arbor, MI, USA.
The thrombolytic protease tissue plasminogen activator (tPA) is expressed in the CNS, where it regulates diverse functions including neuronal plasticity, neuroinflammation, and blood-brain-barrier integrity. However, its role in different brain regions such as the substantia nigra (SN) is largely unexplored. In this study, we characterize tPA expression, activity, and localization in the SN using a combination of retrograde tracing and β-galactosidase tPA reporter mice.
View Article and Find Full Text PDFBMC Med Genomics
January 2025
Sheffield Institute for Translational Neuroscience (SITraN), University of Sheffield, Sheffield, UK.
Amyotrophic lateral sclerosis (ALS) lacks a specific biomarker, but is defined by relatively selective toxicity to motor neurons (MN). As others have highlighted, this offers an opportunity to develop a sensitive and specific biomarker based on detection of DNA released from dying MN within accessible biofluids. Here we have performed whole genome bisulfite sequencing (WGBS) of iPSC-derived MN from neurologically normal individuals.
View Article and Find Full Text PDFMol Imaging Biol
January 2025
Department of Radiology, Weill Cornell Medicine, 413 E 69th Street, Room BB-1604, New York, NY, 10021, USA.
Purpose: Treatment of pediatric cancers with doxorubicin is a common and predictable cause of cardiomyopathy. Early diagnosis of treatment-induced cardiotoxicity and intervention are major determinants for the prevention of advanced disease. The onset of cardiomyopathies is often accompanied by profound changes in lipid metabolism, including an enhanced uptake of short-chain fatty acids (SCFA).
View Article and Find Full Text PDFMol Imaging Biol
January 2025
Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Purpose: This preclinical study explored the feasibility of assessing P-glycoprotein (P-gp) function in both brain and gastrointestinal (GI) tract of rats using positron emission tomography (PET) following oral administration of [F]MC225. Different oral administration protocols were evaluated, and radioactivity uptake was compared with uptake following intravenous administration.
Procedures: Twelve male Wistar rats were divided into four groups and subjected to intravenous or oral [F]MC225 administration protocols: G (intravenous route), G (oral administration without fasting), G (oral administration with fasting), and G (oral administration with fasting following administration of the P-gp inhibitor tariquidar).
Nat Med
January 2025
Merkin Institute of Transformative Technologies in Healthcare, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Prion disease is a fatal neurodegenerative disease caused by the misfolding of prion protein (PrP) encoded by the PRNP gene. While there is currently no cure for the disease, depleting PrP in the brain is an established strategy to prevent or stall templated misfolding of PrP. Here we developed in vivo cytosine and adenine base strategies delivered by adeno-associated viruses to permanently modify the PRNP locus to achieve PrP knockdown in the mouse brain.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!